183 related articles for article (PubMed ID: 38512424)
1. Interleukin 3 Inhibits Glutamate-Cytotoxicity in Neuroblastoma Cell Line.
Matus V; Castro-Guarda M; Cárcamo-Fierro J; Morera FJ; Zambrano A
Neurochem Res; 2024 May; 49(5):1373-1386. PubMed ID: 38512424
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotection by BDNF against glutamate-induced apoptotic cell death is mediated by ERK and PI3-kinase pathways.
Almeida RD; Manadas BJ; Melo CV; Gomes JR; Mendes CS; Grãos MM; Carvalho RF; Carvalho AP; Duarte CB
Cell Death Differ; 2005 Oct; 12(10):1329-43. PubMed ID: 15905876
[TBL] [Abstract][Full Text] [Related]
3. Biologic sequelae of interleukin-6 induced PI3-K/Akt signaling in multiple myeloma.
Hideshima T; Nakamura N; Chauhan D; Anderson KC
Oncogene; 2001 Sep; 20(42):5991-6000. PubMed ID: 11593406
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of Glutamate-Induced Excitotoxicity by Withanolide-A in Neuron-Like Cells: Role for PI3K/Akt/MAPK Signaling Pathway.
Dar NJ; Satti NK; Dutt P; Hamid A; Ahmad M
Mol Neurobiol; 2018 Apr; 55(4):2725-2739. PubMed ID: 28447311
[TBL] [Abstract][Full Text] [Related]
5. Gas1 Knockdown Increases the Neuroprotective Effect of Glial Cell-Derived Neurotrophic Factor Against Glutamate-Induced Cell Injury in Human SH-SY5Y Neuroblastoma Cells.
Wang K; Zhu X; Zhang K; Zhou F; Zhu L
Cell Mol Neurobiol; 2016 May; 36(4):603-11. PubMed ID: 26215053
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotection of interleukin-6 against NMDA-induced neurotoxicity is mediated by JAK/STAT3, MAPK/ERK, and PI3K/AKT signaling pathways.
Fang XX; Jiang XL; Han XH; Peng YP; Qiu YH
Cell Mol Neurobiol; 2013 Mar; 33(2):241-51. PubMed ID: 23161148
[TBL] [Abstract][Full Text] [Related]
7. Protective role of STAT3 in NMDA and glutamate-induced neuronal death: negative regulatory effect of SOCS3.
Park KW; Nozell SE; Benveniste EN
PLoS One; 2012; 7(11):e50874. PubMed ID: 23226414
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-22 promotes the proliferation and migration of hepatocellular carcinoma cells via the phosphoinositide 3-kinase (PI3K/AKT) signaling pathway.
Mansur F; Arshad T; Liska V; Manzoor S
Mol Biol Rep; 2023 Jul; 50(7):5957-5967. PubMed ID: 37264148
[TBL] [Abstract][Full Text] [Related]
9. Catalytic-dependent and -independent roles of SHP-2 tyrosine phosphatase in interleukin-3 signaling.
Yu WM; Hawley TS; Hawley RG; Qu CK
Oncogene; 2003 Sep; 22(38):5995-6004. PubMed ID: 12955078
[TBL] [Abstract][Full Text] [Related]
10. The Neuroprotective Effects of BMSC-Derived Exosomes against Glutamate-Induced HT22 Cell Cytotoxicity.
Rong J; Sun S; Xu SX; Xie XH; Wang C; Chen G; Kang L; Xiang D; Liu Z
Neuroscience; 2024 Mar; 542():1-10. PubMed ID: 38342336
[TBL] [Abstract][Full Text] [Related]
11. The study of traditional Chinese medical elongated-needle therapy promoting neurological recovery mechanism after spinal cord injury in rats.
Shi Y; Quan R; Li C; Zhang L; Du M; Xu J; Yang Z; Yang D
J Ethnopharmacol; 2016 Jul; 187():28-41. PubMed ID: 27085942
[TBL] [Abstract][Full Text] [Related]
12.
Jeong YH; Kim TI; Oh YC; Ma JY
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232743
[TBL] [Abstract][Full Text] [Related]
13. Jak/STAT and PI3K signaling pathways have both common and distinct roles in IL-7-mediated activities in human CD8+ T cells.
Crawley AM; Vranjkovic A; Faller E; McGuinty M; Busca A; Burke SC; Cousineau S; Kumar A; Macpherson PA; Angel JB
J Leukoc Biol; 2014 Jan; 95(1):117-27. PubMed ID: 24072878
[TBL] [Abstract][Full Text] [Related]
14. The neuroprotective action of pyrroloquinoline quinone against glutamate-induced apoptosis in hippocampal neurons is mediated through the activation of PI3K/Akt pathway.
Zhang Q; Shen M; Ding M; Shen D; Ding F
Toxicol Appl Pharmacol; 2011 Apr; 252(1):62-72. PubMed ID: 21320517
[TBL] [Abstract][Full Text] [Related]
15. Signal pathways involved in activation of p70S6K and phosphorylation of 4E-BP1 following exposure of multiple myeloma tumor cells to interleukin-6.
Shi Y; Hsu JH; Hu L; Gera J; Lichtenstein A
J Biol Chem; 2002 May; 277(18):15712-20. PubMed ID: 11872747
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms underlying the action of carcinogens in gastric cancer with a glimpse into targeted therapy.
Patrad E; Khalighfard S; Amiriani T; Khori V; Alizadeh AM
Cell Oncol (Dordr); 2022 Dec; 45(6):1073-1117. PubMed ID: 36149600
[TBL] [Abstract][Full Text] [Related]
17. Salicylidene acylhydrazides attenuate survival of SH-SY5Y neuroblastoma cells through affecting mitotic regulator Speedy/RINGO and ERK/MAPK-PI3K/AKT signaling.
Arziman S; Tanriverdi O; Kucukvardar S; Citil N; Yildiz A
Med Oncol; 2020 Jul; 37(8):65. PubMed ID: 32691165
[TBL] [Abstract][Full Text] [Related]
18. Cudarflavone B provides neuroprotection against glutamate-induced mouse hippocampal HT22 cell damage through the Nrf2 and PI3K/Akt signaling pathways.
Lee DS; Ko W; Kim DC; Kim YC; Jeong GS
Molecules; 2014 Jul; 19(8):10818-31. PubMed ID: 25061726
[TBL] [Abstract][Full Text] [Related]
19. Novel osmotin attenuates glutamate-induced synaptic dysfunction and neurodegeneration via the JNK/PI3K/Akt pathway in postnatal rat brain.
Shah SA; Lee HY; Bressan RA; Yun DJ; Kim MO
Cell Death Dis; 2014 Jan; 5(1):e1026. PubMed ID: 24481440
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-6 activates phosphoinositol-3' kinase in multiple myeloma tumor cells by signaling through RAS-dependent and, separately, through p85-dependent pathways.
Hsu JH; Shi Y; Frost P; Yan H; Hoang B; Sharma S; Gera J; Lichtenstein A
Oncogene; 2004 Apr; 23(19):3368-75. PubMed ID: 15021914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
